As of 2024-10-12, the Fair Value of Tonix Pharmaceuticals Holding Corp (TNXP) is -5.43 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.15 USD, the upside of Tonix Pharmaceuticals Holding Corp is -3,777.81%.
Note: valuation result may not be accurate due to the low predictability of business.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
Historical Earnings | ||||||
2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
Net income | -28.62 | -50.46 | -92.29 | -110.22 | -116.66 | -79.65 |
YoY growth | -9.70% | -76.31% | -82.90% | -19.43% | -5.84% | -38.83% |
Market Cap (mil) | 20.66 |
P/E | |
Forward P/E |
EPS | -219.08 |
Avg earnings growth rate | -38.83% |
TTM earnings |